Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients-Reference-Cited by-同舟云学术

Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients

Published:2023-02-10 Issue:9 Volume:149 Page:6435-6444
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Muendlein Axel^ORCID,Geiger Kathrin,Heinzle Christine,Gaenger Stella,Winder Thomas,Severgnini Luciano,Reimann Patrick,Brandtner Eva Maria,Leiherer Andreas,Drexel Heinz,Decker Thomas,Nonnenbroich Christoph,Dechow Tobias

Funder

INTERREG V program “Alpenrhein-Bodensee-Hochrhein”

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04623-3.pdf

Reference38 articles.

1. Bartolacci C, Andreani C, El-Gammal Y, Scaglioni PP (2021) Lipid metabolism regulates oxidative stress and ferroptosis in RAS-driven cancers: a perspective on cancer progression and therapy. Front Mol Biosci. https://doi.org/10.3389/FMOLB.2021.706650

2. Bouchahda M, Saffroy R, Karaboué A et al (2021) Efficacy of an anti-EGFR after ctDNA conversion from mutated RAS status of metastatic colorectal cancer: results of a pilot study. J Clin Oncol 39:e15574–e15574. https://doi.org/10.1200/jco.2021.39.15_suppl.e15574

3. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

4. Callesen LB, Hamfjord J, Boysen AK et al (2022) Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Br J Cancer 127:500–513. https://doi.org/10.1038/S41416-022-01816-4

5. Campos-da-Paz M, Dórea JG, Galdino AS et al (2018) Carcinoembryonic antigen (CEA) and hepatic metastasis in colorectal cancer: update on biomarker for clinical and biotechnological approaches. Recent Pat Biotechnol 12:269–279. https://doi.org/10.2174/1872208312666180731104244

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases;The Journal of Liquid Biopsy;2024-06

2. Liquid biopsy in colorectal cancer: Onward and upward;Critical Reviews in Oncology/Hematology;2024-02

3. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis;Open Life Sciences;2023-01-01